MicroRNAs as pharmacological targets in diabetes.
MicroRNAs as pharmacological targets in diabetes.
复制标题
DOI:
10.1016/j.phrs.2013.06.005
复制
发表时间:
2013-09
影响因子:
9.3
通讯作者:
Tang, Xiaoqing
中科院分区:
文献类型:
--
作者:
Mao, Yiping;Mohan, Ramkumar;Zhang, Shungang;Tang, Xiaoqing
Diabetes is characterized by high levels of blood glucose due to either the loss of insulin-producing beta-cells in the pancreas, leading to a deficiency of insulin in type 1 diabetes, or due to increased insulin resistance, leading to reduced insulin sensitivity and productivity in type 2 diabetes. There is an increasing need for new options to treat diabetes, especially type 2 diabetes at its early stages due to the ineffective control of its development in patients. Recently, a novel class of small noncoding RNAs, termed microRNAs (miRNAs), found to play a key role as important transcriptional and posttranscriptional inhibitors of gene expression in fine-tuning the target messenger RNAs (mRNAs). miRNAs are implicated in the pathogenesis of diabetes and have become an intriguing target for therapeutic intervention. This review focuses on the dysregulated miRNAs discovered in various diabetic models and addresses the potential for miRNAs to be therapeutic targets in the treatment of diabetes.
登录
查看更多内容
影响因子:
9.8
作者:
Bordone L;Motta MC;Picard F;Robinson A;Jhala US;Apfeld J;McDonagh T;Lemieux M;McBurney M;Szilvasi A;Easlon EJ;Lin SJ;Guarente L
通讯作者:
Guarente L
影响因子:
3.1
作者:
Andersson, Patrik;Gidlof, Olof;Erlinge, David
通讯作者:
Erlinge, David
DOI:
10.2174/157489010793351962
发表时间:
2010-11-01
期刊:
Recent patents on cardiovascular drug discovery
影响因子:
--
作者:
Bonci, Desiree
通讯作者:
Bonci, Desiree
DOI:
10.1016/j.beem.2011.12.002
发表时间:
2012-04-01
影响因子:
7.4
作者:
Barker, Adam;Langenberg, Claudia;Wareham, Nicholas J.
通讯作者:
Wareham, Nicholas J.
影响因子:
4.2
作者:
Cusi, Kenneth
通讯作者:
Cusi, Kenneth